Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ARISE: Sebelipase alfa in LAL-D
NCT01757184Phase 3Completed
- Sponsor
- Alexion Pharmaceuticals
- Start
- Jan 2013
- Primary completion
- May 2014
- Modality
- Replacement Enzymes
- Countries
- 15
01
Overview
A Phase 3 trial of sebelipase alfa in lysosomal acid lipase deficiency (LALD), sponsored by Alexion Pharmaceuticals. Started Jan 2013; status: completed.
02
Drugs
sebelipase alfa
03
Conditions
lysosomal acid lipase deficiency (LALD)
Beyond the preview
Go deeper on NCT01757184.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01757184.